Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Wearable Injectors Market Expected to Grow Between 2025 And 2029?

In the past few years, the wearable injectors market has experienced a significant increase in size. It is projected to expand from $8.84 billion in 2024 to a value of $9.91 billion in 2025, marking a compound annual growth rate (CAGR) of 12.1%. The surge in growth during the historic period is linked to factors like chronic disease management, convenience for patients, technological developments, and an aging population.

What Growth Rate Is Anticipated for the Wearable Injectors Market in the Coming Years?

In the coming years, the market size of wearable injectors is predicted to experience a steep surge. The market size is estimated to rise to $17.45 billion in 2029, with a compound annual growth rate (CAGR) of 15.2%. Factors contributing to the anticipated growth in the forecast period encompass personalized medicine, remote patient monitoring, drug development, and chronic disease management. Some of the significant trends for the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, along with patch pump technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3308&type=smp

Who Are the Leading Companies in the Wearable Injectors Market?

Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical plc, United Therapeutics Corporation, Bühler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd, Zosano Pharma Corporation

What Are the Key Drivers of the Wearable Injectors Market?

The escalation in the occurrence of chronic illnesses such as diabetes, cardiovascular diseases, and cancers is a major contributor to the growth of the wearable injectors market. The British Diabetic Association, a charity based in the UK for individuals coping with diabetes, reported in April 2023 that approximately 4.3 million people in the UK have been diagnosed with diabetes. Of these, around 90% are suffering from type 2 diabetes and about 8% are coping with type 1 diabetes, while the other 2% are accounted for by other types of diabetes. This rise in the population of diabetic and chronic disease patients has propelled the demand for disease treatment, consequently boosting the expansion of the wearable injectors market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3308&type=smp

What Are the Key Market Segments in the Wearable Injectors Industry?

The wearable injectors market covered in this report is segmented –

1) By Type: On-Body Injectors, Off-Body Injectors

2) By End-User: Hospitals, Clinics, Homecare setting

3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications

Subsegments:

1) By On-Body Injectors: Patch-Based Injectors, Adhesive-Based Injectors, Needle-Based Injectors, Needle-Free Injectors

2) By Off-Body Injectors: Belt-Based Injectors, Handheld Injectors, Clip-Based Injectors

What Are the Latest Trends in the Wearable Injectors Market?

A multitude of businesses within the wearable injectors manufacturing sector are prioritizing the design of innovative products such as on-body injectors (OBIs), aiming to heighten patient comfort, boost compliance with prescribed regimens, and cater to the escalating demand for self-administration of biologics. The on-body injector (OBI) is a wearable device designed to deliver medication subcutaneously over a specified time, providing convenience for patients requiring large-volume or time-dosed injections. For example, in February 2024, Coherus BioSciences Inc., an American biotechnology firm, introduced UDENYCA. This device, developed using the LTS Sorrel wearable platform, is engineered expressly for the administration of pegfilgrastim-cbqv, a pegfilgrastim biosimilar. This drug is utilized post-chemotherapy to reduce the likelihood of febrile neutropenia, a condition marked by fever and depleted numbers of white blood cells triggered by infections. The OBI facilitates accurate dosage and convenience for patients through its enablement of home-based administration, thereby removing the need for further clinical appointments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/wearable-injectors-global-market-report

What Are the Key Regional Markets in the Wearable Injectors Industry?

North America was the largest region in the wearable injectors market in 2023. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3308

This Report Delivers Insight On:

1. How big is the wearable injectors market, and how is it changing globally?

2. Who are the major companies in the wearable injectors market, and how are they performing?

3. What are the key opportunities and risks in the wearable injectors market right now?

4. Which products or customer segments are growing the most in the wearable injectors market?

5. What factors are helping or slowing down the growth of the wearable injectors market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model